Related Experiment Video

Updated: May 15, 2026

Screening Ion Channels in Cancer Cells
06:19

Screening Ion Channels in Cancer Cells

Published on: June 16, 2023

Ion channels and transporters in cancer: pathophysiology, regulation, and clinical potential

Stine Falsig Pedersen1, Christian Stock

  • 1Department of Biology, University of Copenhagen, Copenhagen, Denmark. sfpedersen@bio.ku.dk

Cancer Research
|January 11, 2013
PubMed

Insights

Dysregulated ion channels and transporters (ICTs) are crucial in cancer development and progression. Targeting ICTs offers promising new avenues for cancer therapy, diagnosis, and prognosis.

Area of Science:

  • Oncology
  • Molecular Biology
  • Physiology

Background:

  • Ion channels and transporters (ICTs) play critical roles in cellular functions.
  • Over the past 15 years, evidence has accumulated showing ICT dysregulation in all cancer types.
  • ICTs are increasingly recognized as key players in cancer hallmarks.

Framework:

  • A colloquium on "Ion Transport and Cancer" convened experts to discuss the multifaceted roles of ICTs.
  • Discussions covered ICT involvement in cancer cell proliferation, apoptosis, motility, invasion, and the tumor microenvironment.
  • Specific focus was given to pancreatic ductal adenocarcinoma and transport protein-based strategies.

Implementation:

  • The colloquium highlighted the consensus that ICT dysregulation is integral to cancer.
  • The current status of ICTs as therapeutic, diagnostic, and prognostic targets was reviewed.
  • Discussions emphasized the need for further mechanistic studies and therapeutic development.

Implications:

  • Dysregulated ICTs are fundamental to cancer biology, offering novel therapeutic targets.
  • Further research into ICT mechanisms will drive the development of innovative cancer treatments.
  • Targeting ICTs holds significant potential for improving cancer diagnostics and prognostics.

More Related Videos

Generation of Organ-conditioned Media and Applications for Studying Organ-specific Influences on Breast Cancer Metastatic Behavior09:44

Generation of Organ-conditioned Media and Applications for Studying Organ-specific Influences on Breast Cancer Metastatic Behavior

Published on: June 13, 2016

Related Concept Videos

Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
The Significance of Membrane Transport01:44

The Significance of Membrane Transport

The transport of solutes across the cell membrane is essential for metabolic processes, like maintaining cell size and volume, generating the action potential, exchanging nutrients and gases, etc. Membrane transport can be either passive or active. It can be simple diffusion, facilitated, or mediated transport aided by transport proteins such as transporters and channels.
Transporters facilitate either an active or passive movement of solutes. They can allow a single-molecule transport down its...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...